Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LUNDENS HESTEKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.6% 5.7% 9.5% 9.1% 7.2% 10.2% 20.6% 20.4%   Credit score (0-100)   38 41 26 26 33 23 5 5   Credit rating   BBB BBB BB BB BBB BB B B   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,140 1,057 1,520 2,090 2,075 1,759 0.0 0.0   EBITDA   131 -43.6 -6.8 368 430 126 0.0 0.0   EBIT   123 -51.6 -21.2 342 388 46.1 0.0 0.0   Pre-tax profit (PTP)   117.0 -108.3 -69.4 292.2 352.6 2.8 0.0 0.0   Net earnings   117.0 -82.9 -69.4 208.9 272.7 17.8 0.0 0.0   Pre-tax profit without non-rec. items   117 -108 -69.4 292 353 2.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   23.0 17.0 74.6 97.4 312 545 0.0 0.0   Shareholders equity total   -529 -612 -682 -473 -200 -182 -262 -262   Interest-bearing liabilities   841 896 679 660 596 390 262 262   Balance sheet total (assets)   566 603 591 630 990 950 0.0 0.0   Net Debt   706 782 582 628 563 386 262 262     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,140 1,057 1,520 2,090 2,075 1,759 0.0 0.0   Gross profit growth   31.1% -7.3% 43.8% 37.5% -0.7% -15.2% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   566 603 591 630 990 950 0 0   Balance sheet change%   -18.9% 6.7% -2.0% 6.5% 57.2% -4.1% -100.0% 0.0%   Added value   131.4 -43.6 -6.8 367.7 412.7 126.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -14 -14 43 -2 172 153 -545 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.8% -4.9% -1.4% 16.4% 18.7% 2.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.7% -2.8% -1.2% 29.5% 35.5% 5.0% 0.0% 0.0%   ROI %   17.5% -3.8% -1.9% 52.4% 64.6% 11.7% 0.0% 0.0%   ROE %   18.5% -14.2% -11.6% 34.2% 33.7% 1.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -48.3% -50.4% -53.6% -42.9% -16.8% -16.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   537.2% -1,793.8% -8,524.8% 170.7% 131.1% 305.3% 0.0% 0.0%   Gearing %   -158.8% -146.3% -99.7% -139.5% -298.0% -214.1% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.5% 8.7% 6.9% 8.7% 8.7% 11.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.0   Current Ratio   0.4 0.4 0.3 0.4 0.4 0.4 0.0 0.0   Cash and cash equivalent   135.2 114.1 97.2 32.0 32.9 4.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -640.5 -727.1 -861.0 -652.5 -729.7 -727.4 -131.1 -131.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   66 -22 -3 184 206 63 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   66 -22 -3 184 215 63 0 0   EBIT / employee   62 -26 -11 171 194 23 0 0   Net earnings / employee   59 -41 -35 104 136 9 0 0